Table of Contents Author Guidelines Submit a Manuscript
Parkinson’s Disease
Volume 2015, Article ID 970534, 8 pages
http://dx.doi.org/10.1155/2015/970534
Research Article

Minimal Clinically Important Difference on Parkinson’s Disease Sleep Scale 2nd Version

1Doctoral School of Clinical Neuroscience, University of Pécs, Rét Utca 2, Pécs 7623, Hungary
2Department of Neurology, University of Pécs, Rét Utca 2, Pécs 7623, Hungary
3MTA-PTE Clinical Neuroscience MR Research Group, Rét Utca 2, Pécs 7623, Hungary

Received 28 June 2015; Accepted 10 September 2015

Academic Editor: Birgit Högl

Copyright © 2015 Krisztina Horváth et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Santos-García and R. De La Fuente-Fernández, “Impact of non-motor symptoms on health-related and perceived quality of life in Parkinson's disease,” Journal of the Neurological Sciences, vol. 332, no. 1-2, pp. 136–140, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Martinez-Martin, C. Rodriguez-Blazquez, M. M. Kurtis, and K. R. Chaudhuri, “The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's disease,” Movement Disorders, vol. 26, no. 3, pp. 399–406, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Trenkwalder, R. Kohnen, B. Högl et al., “Parkinson's disease sleep scale—validation of the revised version PDSS-2,” Movement Disorders, vol. 26, no. 4, pp. 644–652, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Suzuki, M. Miyamoto, T. Miyamoto et al., “Nocturnal disturbances and restlessness in Parkinson's disease: using the Japanese version of the Parkinson's disease sleep scale-2,” Journal of the Neurological Sciences, vol. 318, no. 1-2, pp. 76–81, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Horváth, Z. Aschermann, P. Ács et al., “Is the MDS-UPDRS a good screening tool for detecting sleep problems and daytime sleepiness in Parkinson's disease?” Parkinson's Disease, vol. 2014, Article ID 806169, 8 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Horváth, Z. Aschermann, P. Ács et al., “Test-retest validity of Parkinson's disease sleep scale 2nd version (PDSS-2),” Journal of Parkinson's Disease, vol. 4, no. 4, pp. 687–691, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Kovács, E. Pál, J. Janszky et al., “Parkinson's disease sleep scale-2 and Epworth sleep scale,” Journal of the Neurological Sciences, vol. 333, p. e139, 2013. View at Google Scholar
  8. T. J. Swick, J. H. Friedman, K. R. Chaudhuri et al., “Associations between severity of motor function and nonmotor symptoms in Parkinson's disease: a post hoc analysis of the RECOVER Study,” European Neurology, vol. 71, no. 3-4, pp. 140–147, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Takanashi, Y. Shimo, T. Hatano, G. Oyama, and N. Hattori, “Efficacy and safety of a once-daily extended-release formulation of pramipexole switched from an immediate-release formulation in patients with advanced Parkinson's disease: results from an open-label study,” Drug Research, vol. 63, no. 12, pp. 639–643, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Zibetti, M. Rizzone, A. Merola et al., “Sleep improvement with levodopa/carbidopa intestinal gel infusion in Parkinson disease,” Acta Neurologica Scandinavica, vol. 127, no. 5, pp. e28–e32, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Ghys, E. Surmann, J. Whitesides, and B. Boroojerdi, “Effect of rotigotine on sleep and quality of life in Parkinson's disease patients: post hoc analysis of RECOVER patients who were symptomatic at baseline,” Expert Opinion on Pharmacotherapy, vol. 12, no. 13, pp. 1985–1998, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Kovács, Z. Aschermann, P. Ács et al., “The impact of levodopa-carbidopa intestinal gel on health-related quality of life in Parkinson's disease,” Ideggyogyaszati Szemle, vol. 67, no. 7-8, pp. 245–250, 2014. View at Google Scholar · View at Scopus
  13. G. Deli, Z. Aschermann, P. Ács et al., “Bilateral subthalamic stimulation can improve sleep quality in Parkinson's disease,” Journal of Parkinson's Disease, vol. 5, no. 2, pp. 361–368, 2015. View at Publisher · View at Google Scholar
  14. R. Jaeschke, G. H. Guyatt, D. Cook et al., “Effect of increasing doses of beta agonists on spirometric parameters, exercise capacity, and quality of life in patients with chronic airflow limitation,” Thorax, vol. 49, no. 5, pp. 479–484, 1994. View at Publisher · View at Google Scholar · View at Scopus
  15. R. A. Hauser and P. Auinger, “Determination of minimal clinically important change in early and advanced Parkinson's disease,” Movement Disorders, vol. 26, no. 5, pp. 813–818, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. L. M. Shulman, A. L. Gruber-Baldini, K. E. Anderson, P. S. Fishman, S. G. Reich, and W. J. Weiner, “The clinically important difference on the unified parkinson's disease rating scale,” Archives of Neurology, vol. 67, no. 1, pp. 64–70, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. R. A. Hauser, M. F. Gordon, Y. Mizuno et al., “Minimal clinically important difference in parkinson's disease as assessed in pivotal trials of pramipexole extended release,” Parkinson's Disease, vol. 2014, Article ID 467131, 8 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Revicki, R. D. Hays, D. Cella, and J. Sloan, “Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes,” Journal of Clinical Epidemiology, vol. 61, no. 2, pp. 102–109, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. I. Litvan, K. P. Bhatia, D. J. Burn et al., “SIC task force appraisal of clinical diagnostic criteria for parkinsonian disorders,” Movement Disorders, vol. 18, no. 5, pp. 467–486, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. B. Kaszás, N. Kovács, I. Balás et al., “Sensitivity and specificity of addenbrooke's cognitive examination, mattis dementia rating scale, frontal assessment battery and mini mental state examination for diagnosing dementia in Parkinson's disease,” Parkinsonism and Related Disorders, vol. 18, no. 5, pp. 553–556, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Lucza, K. Karádi, J. Kállai et al., “Screening mild and major neurocognitive disorders in Parkinson's disease,” Behavioural Neurology, vol. 2015, Article ID 983606, 10 pages, 2015. View at Publisher · View at Google Scholar
  22. T. Lucza, K. Karádi, S. Komoly et al., “Neurokognitív zavarok diagnosztizálási és kezelési lehetőségei Parkinson-kórban,” Orvosi Hetilap, vol. 156, no. 23, pp. 915–926, 2015. View at Publisher · View at Google Scholar
  23. K. Horváth, Z. Aschermann, P. Ács et al., “Validation of the Hungarian MDS-UPDRS: why do we need a new Parkinson scale?” Ideggyogyaszati Szemle, vol. 67, no. 3-4, pp. 129–134, 2014. View at Google Scholar · View at Scopus
  24. C. G. Goetz, B. C. Tilley, S. R. Shaftman et al., “Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results,” Movement Disorders, vol. 23, no. 15, pp. 2129–2170, 2008. View at Publisher · View at Google Scholar
  25. M. M. Hoehn and M. D. Yahr, “Parkinsonism: onset, progression and mortality,” Neurology, vol. 17, no. 5, pp. 427–442, 1967. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Schwab and A. England, “Projection technique for evaluating surgery in Parkinson's disease,” in Third Symposium on Parkinson's Disease, F. Gillingham and M. Donaldson, Eds., pp. 152–157, E & S Livingstone, Edinburgh, Scotland, 1969. View at Google Scholar
  27. C. G. Goetz, W. Poewe, O. Rascol et al., “Movement disorder society task force report on the hoehn and yahr staging scale: status and recommendations,” Movement Disorders, vol. 19, no. 9, pp. 1020–1028, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Jaeschke, J. Singer, and G. H. Guyatt, “Measurement of health status. Ascertaining the minimal clinically important difference,” Controlled Clinical Trials, vol. 10, no. 4, pp. 407–415, 1989. View at Publisher · View at Google Scholar · View at Scopus
  29. G. Samsa, D. Edelman, M. L. Rothman, G. R. Williams, J. Lipscomb, and D. Matchar, “Determining clinically important differences in health status measures: a general approach with illustration to the Health Utilities Index Mark II,” PharmacoEconomics, vol. 15, no. 2, pp. 141–155, 1999. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Perez-Lloret, M. Rossi, M. I. Nouzeilles, C. Trenkwalder, D. P. Cardinali, and M. Merello, “Parkinson's disease sleep scale, sleep logs, and actigraphy in the evaluation of sleep in parkinsonian patients,” Journal of Neurology, vol. 256, no. 9, pp. 1480–1484, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. Uemura, T. Nomura, Y. Inoue, M. Yamawaki, K. Yasui, and K. Nakashima, “Validation of the parkinson's disease sleep scale in japanese patients: a comparison study using the pittsburgh sleep quality index, the epworth sleepiness scale and polysomnography,” Journal of the Neurological Sciences, vol. 287, no. 1-2, pp. 36–40, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. A. F. Mannion, F. Porchet, F. S. Kleinstück et al., “The quality of spine surgery from the patient's perspective: part 2. Minimal clinically important difference for improvement and deterioration as measured with the Core Outcome Measures Index,” European Spine Journal, vol. 18, supplement 3, pp. S374–S379, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. C. Trenkwalder, B. Kies, M. Rudzinska et al., “Rotigotine effects on early morning motor function and sleep in Parkinson's disease: a double-blind, randomized, placebo-controlled study (RECOVER),” Movement Disorders, vol. 26, no. 1, pp. 90–99, 2011. View at Publisher · View at Google Scholar · View at Scopus